Alison Armour

2019

In 2019, Alison Armour earned a total compensation of $2.7M as Former Senior Vice President, Head of Research & Development at Halozyme Therapeutics.

Compensation breakdown

Bonus$200,000
Non-Equity Incentive Plan$152,324
Option Awards$1,000,002
Salary$324,375
Stock Awards$1,000,006
Other$1,990
Total$2,678,697

Armour received $1M in stock awards, accounting for 37% of the total pay in 2019.

Armour also received $200K in bonus, $152.3K in non-equity incentive plan, $1M in option awards, $324.4K in salary and $2K in other compensation.

Rankings

In 2019, Alison Armour's compensation ranked 4,562nd out of 13,971 executives tracked by ExecPay. In other words, Armour earned more than 67.3% of executives.

ClassificationRankingPercentile
All
4,562
out of 13,971
67th
Division
Manufacturing
1,704
out of 5,701
70th
Major group
Chemicals And Allied Products
597
out of 2,200
73rd
Industry group
Drugs
503
out of 1,886
73rd
Industry
Biological Products, Except Diagnostic Substances
109
out of 389
72nd

Pay ratio

Alison Armour's Pay$2,678,697
Median Employee's Pay$238,096
Pay Ratio

11

to 1

In 2019, the annual total compensation of Alison Armour was $2,678,697.

The annual total compensation of the median employee at Halozyme Therapeutics was $238,096.

The ratio of Alison Armour's pay to the pay of median employee was therefore 11 to one.

Source: SEC filing on March 20, 2020.

Armour's colleagues

We found four more compensation records of executives who worked with Alison Armour at Halozyme Therapeutics in 2019.

2019

Helen Torley

Halozyme Therapeutics

Chief Executive Officer

2019

Laurie Stelzer

Halozyme Therapeutics

Chief Financial Officer

2019

Benjamin Hickey

Halozyme Therapeutics

Former Senior Vice President, Chief Commercial Officer

2019

Harry Leonhardt

Halozyme Therapeutics

General Counsel

News

You may also like